Flat-Rate vs Dose-Based GLP-1 Pricing: Which Saves More in 2026?

Last reviewed: September 24, 2026 Last updated: September 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Flat-rate programs—where one monthly price covers every dose from start through maintenance—generally save money over 12 months when a patient reaches and sustains a mid-to-high titration dose. Dose-based programs can cost less in the first few months at starter doses but become more expensive as the dose increases, often by $50–150 per month at typical maintenance levels. If you expect to titrate beyond the lowest dose and remain on therapy for six months or more, flat-rate pricing usually delivers lower total cost and eliminates surprise increases at dose changes. If you plan a short trial or expect to stay at the starting dose, a low introductory rate on a dose-tiered program may be cheaper in the near term.

At-a-glance comparison

Membership fees and medication costs are combined where applicable. Dose-based models publish starting-dose rates; maintenance rates depend on the prescribed titration schedule.

Normalized 12-month cost comparison

To compare total cost, we model a representative 12-month scenario: months 1–3 at a starting dose, months 4–12 at a maintenance dose. For dose-based programs that do not publish a maintenance rate, we cannot calculate a 12-month figure. For flat-rate programs, the calculation is straightforward. All figures below are our calculations unless the provider publishes an explicit 12-month total.

Semaglutide injection, 12-month total

OrderlyMeds shows the lowest 12-month total at $1,639, driven by a two-month $149 starter bundle and $149 ongoing rate. However, Trustpilot reports from September 2026 include complaints of fast charging but slow refunds, non-response, delayed shipping, pharmacy changes, and unwanted calls and texts after opt-out (Trustpilot, 3.6 stars / ~634 reviews, captured 2026-09-04). PlexusDx places second at $2,268, holding a 4.3-star Trustpilot rating with 79% five-star reviews and 83% four-star or higher (captured 2026-09-09). Eden's $2,316 includes a $99/month ongoing membership; MEDVi's $2,870 reflects a $179 first month and $299 refills.

Tirzepatide injection, 12-month total

Eden offers the lowest 12-month tirzepatide total at $2,920, though the ongoing $298/month includes a $99 membership fee and one Trustpilot report from September 2026 describes an 11-day order delay and repeated requests for records Eden had previously issued (Trustpilot, 4.5 stars / ~5K reviews, captured 2026-09-04). OrderlyMeds places second at $3,289 but carries the service concerns noted above. PlexusDx is third at $3,468, $548 more than Eden over 12 months but with no separate membership and a 4.3-star Trustpilot profile.

When dose-based pricing costs less

Dose-based programs advertise a lower entry point—Mochi Health starts semaglutide at $99 per month starting dose (medication $60 + first-month $39 membership promo) and tirzepatide at $129 per month starting dose (medication $90 + first-month $39 membership promo), both captured September 4, 2026. If you remain at the starting dose for the full 12 months and your provider does not titrate you upward, the starting-dose rate would total $1,188 for semaglutide or $1,548 for tirzepatide, well below any flat-rate competitor in the table above.

In practice, most GLP-1 protocols titrate patients over weeks or months to reach an effective dose, and dose-based programs raise the monthly price with each increase. Mochi Health's published pricing confirms that "higher doses cost more" but does not disclose a rate schedule beyond the starting tier (captured 2026-09-04). Without visibility into mid- and high-dose pricing, a patient cannot forecast total cost or compare accurately against flat-rate options before enrollment.

Trustpilot shows Mochi Health at 4.5 stars from approximately 18,000 reviews (captured 2026-09-04). One September 2026 report alleges a provider appearing late to a video visit and not engaging during the consultation.

Flat-rate advantages: predictability and breakeven

Flat-rate programs eliminate price surprises at dose changes. PlexusDx charges $189 per month for compounded semaglutide injection and $289 per month for compounded tirzepatide injection at every dose level, month-to-month with no membership fee (captured 2026-07-17 to 2026-07-23). A patient who begins at 0.25 mg semaglutide weekly and titrates to 2.4 mg pays the same $189 every month; the same holds for tirzepatide at any dose from 2.5 mg to 15 mg weekly.

This structure favors patients who:

• Expect to reach and sustain a mid-to-high maintenance dose over six months or more.
• Value budget predictability and want to avoid mid-therapy price increases.
• Plan to remain on therapy long-term and prefer locking in a constant rate.

For semaglutide, PlexusDx at $189/month sits $9/month below Eden's $198 ongoing all-in rate (after the first-month $39 membership promo) and $110/month below MEDVi's $299 refill rate. For tirzepatide, PlexusDx at $289/month is $9/month below Eden's $298 ongoing rate and $110/month below MEDVi's $399 refill rate. Over 12 months, these differences compound: PlexusDx saves $48 versus Eden on semaglutide ($2,268 vs $2,316) and $548 versus itself on tirzepatide when compared to Eden ($3,468 vs $2,920—Eden is lower). OrderlyMeds undercuts both on nominal 12-month totals but carries the service-risk profile described above.

Prepaid discounts and effective monthly rates

Several flat-rate programs lower the effective monthly cost when you prepay multiple months. These rates remain flat across doses but require upfront payment and sometimes lock you into a term.

Henry Meds prepaid semaglutide

• Month-to-month: $297/month ($3,564 over 12 months)
• 6-month prepaid: $1,782 standard or $1,482 with discount ($247/month or $247/month effective—our calculation; evidence shows two figures, confirm at checkout)
• 12-month prepaid: $3,564 standard or $2,364 with discount ($297/month or $197/month effective—our calculation)

Captured September 4, 2026. The $197/month 12-month effective rate is $8/month more than PlexusDx's $189 month-to-month, but Henry Meds requires $2,364 upfront and does not offer tirzepatide injection (tirzepatide is available only as an oral dissolving tablet).

Found prepaid plans

• Cash-pay monthly: $289/month ($3,468 over 12 months)
• Cash-pay annual prepaid: $2,028 upfront ($169/month effective—our calculation)
• Insurance-support monthly: $199/month + typical ~$30 copay
• Insurance-support annual prepaid: $1,188 upfront ($99/month effective—our calculation) + copays

Captured September 4, 2026. The $169/month cash-pay effective rate is $20/month less than PlexusDx's $189 semaglutide month-to-month, but requires $2,028 upfront. Found's Trustpilot profile shows 4.1 stars from ~732 reviews (captured 2026-09-04).

Hims & Hers compounded semaglutide

• 6-month prepaid: $1,194 ($199/month effective—our calculation); requires six-month prepay

Captured September 4, 2026. The $199/month effective rate is $10/month more than PlexusDx's $189 month-to-month and requires $1,194 upfront. Trustpilot shows 10,094 reviews (rating not captured); negative themes include perceived lack of efficacy, side effects, and uncancelled renewal regret.

Membership fees and all-in cost

Programs that separate medication cost from a membership fee require careful addition to determine the true monthly outlay:

• Eden: $99 medication + $99 membership = $198/month semaglutide ongoing; $199 medication + $99 membership = $298/month tirzepatide ongoing (first month $39 membership promo). Captured 2026-09-04.
• Mochi Health: Starting dose $60 semaglutide or $90 tirzepatide medication + $39 membership (first month $39 promo, then ongoing $39). Higher doses increase medication cost; the membership fee remains $39. Captured 2026-09-04.
• Ro Body Program: $149/month membership + separate medication ($149–299/month for branded semaglutide pill, dose-dependent; $299–449/month for branded tirzepatide, dose-dependent). First month $39. Prepaid membership options: six months $534 ($89/month effective) or 12 months $888 ($74/month effective)—our calculation. Captured 2026-09-04. Trustpilot reports describe confusing separate costs, prior-authorization friction, customer service issues, and perceived weak efficacy.
• WeightWatchers Clinic: Service membership + medication generally extra; Med+ 12-month promo advertises first two months $25/month, then $74/month. Branded medication (e.g. semaglutide pill) $149–299/month, dose-dependent. Trustpilot (4 stars / 4,646 reviews, captured 2026-09-04) includes reports of annual or six-month lock-in, charges after attempted cancellation, insurance denial, and slow or nonexistent clinical communication.

PlexusDx, Henry Meds, Embody, Peak Wellness, MEDVi, OrderlyMeds, and Fridays Health charge no separate membership fee; the published monthly rate is all-inclusive for medication, provider visit, and shipping.

Risk of mid-therapy price increases

When a dose-based program does not publish its full rate card, you cannot know the cost of the next titration step until your provider prescribes it. If your starting-dose rate is $99/month and your maintenance-dose rate turns out to be $199 or $249/month, your budget increases by $100–150 per month mid-therapy. Flat-rate programs eliminate this risk.

One strategy: if a dose-based program offers a short-term advantage and you plan only a three-month trial, the low starting rate may save money in that window. If you respond well and decide to continue for 6–12 months, calculate the crossover point where cumulative cost under the dose-tiered model exceeds a flat-rate alternative, then consider switching providers before that point.

Switching between programs

GLP-1 therapy is portable. If you begin with one provider and later find better pricing or service elsewhere, you can request your medical records, complete a new intake with the second provider, and ask that provider to write a new prescription. Most telehealth platforms require their own clinical evaluation and will not automatically honor an outside prescription, but a licensed clinician can review your documented history and prescribe the same compound and dose if clinically appropriate.

No provider in this comparison guarantees that a transfer will be uninterrupted, that your dose will remain unchanged, or that approval is automatic. Each platform's clinician makes an independent prescribing decision.

Decision factors beyond price

Lowest 12-month cost is not the only variable:

• Service quality and responsiveness: Trustpilot and Reddit anecdotes from September 2026 describe delayed shipments, non-responses, pharmacy changes, and billing issues at some low-cost providers. PlexusDx holds a 4.3-star Trustpilot rating with 79% five-star reviews (captured 2026-09-09); Mochi Health 4.5 stars / ~18K reviews; Henry Meds 4.4 stars / ~13K reviews; Eden 4.5 stars / ~5K reviews; MEDVi 4.3 stars / ~15K reviews; OrderlyMeds 3.6 stars / ~634 reviews (all captured 2026-09-04).
• Formulary and route options: Some programs offer only injection, some only oral, some both. Henry Meds offers semaglutide injection but tirzepatide only as an oral dissolving tablet. Eden's injectable and oral availability varies by clinician.
• Prepay requirements: Lower effective monthly rates often require three-, six-, or twelve-month upfront payment, locking your capital and creating exit friction if you experience intolerable side effects or lose efficacy.
• Flexibility to pause or cancel: Month-to-month plans allow you to stop without forfeiting prepaid months. Prepaid plans do not.

Choose a flat-rate program if…

• You expect to reach a mid-to-high maintenance dose and remain on therapy for six months or longer.
• You value predictable monthly costs and want to avoid surprise increases at dose changes.
• You prefer month-to-month flexibility without prepaying multiple months.
• You want transparency: knowing today what month 8 or month 12 will cost.

Choose a dose-based program if…

• You plan a short trial (three months or less) and the starting-dose rate offers meaningful savings during that window.
• Your clinician expects you to remain at a low dose long-term, and the provider publishes that tier's rate so you can confirm ongoing cost.
• You are willing to accept mid-therapy price increases in exchange for a lower entry point.
• The provider publishes a full dose-price schedule so you can model total cost before enrollment (most do not).

Where PlexusDx fits

PlexusDx operates a flat-rate model with no membership fee. Compounded semaglutide injection is $189 per month and compounded tirzepatide injection is $289 per month, month-to-month, at every dose from start through maintenance (captured 2026-07-17 to 2026-07-23). The program also offers oral semaglutide ($289/month month-to-month, $269/month on a three-month plan, $249/month on a six-month plan), oral tirzepatide ($349/month month-to-month, $299/month on a three-month plan, $279/month on a six-month plan), and a microdose GLP-1 injection option at $129 per month for patients seeking a lower-intensity maintenance protocol (all captured 2026-09-24).

Over 12 months, PlexusDx's semaglutide injection total of $2,268 ranks second among the programs that publish full pricing, $48 less than Eden's $2,316 (which includes a $99/month membership) and $602 less than MEDVi's $2,870 (which includes a $179 first month and $299 refills). OrderlyMeds' $1,639 total is lower, but Trustpilot reports from September 2026 describe service and communication issues. For tirzepatide injection, Eden's $2,920 is $548 less than PlexusDx's $3,468, but Eden's rate includes the $99/month membership and one September 2026 Trustpilot report describes an 11-day delay and repeated record requests.

PlexusDx holds a 4.3-star Trustpilot rating, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). The platform works with licensed 503A compounding pharmacies and includes provider visit, prescription, compounded medication, and shipping in the published monthly rate.

Methodology and freshness

Pricing, membership fees, dose policies, and review ratings were captured from provider websites, checkout flows, and Trustpilot profiles between July 17 and September 24, 2026. Where a provider advertises an introductory or promotional rate, we label it explicitly and present it alongside the ongoing or refill rate so the reader sees the true recurring cost. Twelve-month totals are our calculation, modeling three months at a starting or introductory rate (where applicable) and nine months at the ongoing rate, except where a provider publishes an explicit annual figure. We do not perform discount arithmetic to derive figures not observed; every price in this article was captured directly from the source cited. If a dose-based program does not publish maintenance-dose pricing, we state that the 12-month total cannot be calculated. All monetary figures are in USD and reflect the cash-pay path unless otherwise noted.

Frequently Asked Questions

Does a flat-rate GLP-1 program always cost less than a dose-based program over 12 months?

Not always. If you remain at the starting dose for the entire year and do not titrate upward, a dose-based program's low entry rate may result in a lower 12-month total. In practice, most patients titrate to higher doses, and dose-based programs raise the monthly price with each increase, often surpassing flat-rate totals by month six or earlier.

Can I switch GLP-1 providers mid-therapy if I find better pricing?

Yes. Request your medical records from your current provider, complete an intake with the new provider, and their licensed clinician will review your history and determine whether they can prescribe the same compound and dose. No provider guarantees uninterrupted transfer, automatic approval, or that your dose will remain unchanged.

Why don't dose-based programs publish pricing for every dose tier?

Many dose-based platforms publish only the starting-dose rate and state that higher doses cost more without disclosing a full schedule. This limits the ability to forecast total cost before enrollment. When comparing options, ask the provider for a complete rate card or confirm the price of your expected maintenance dose before committing.

Do membership fees stay the same when medication prices increase?

Generally, yes. Programs that separate a membership fee from medication cost (such as Eden and Mochi Health) typically hold the membership fee constant while raising the medication charge as dose increases. Confirm this structure during intake so you know which line item will change and by how much.

If I prepay six or twelve months for a lower effective monthly rate, can I get a refund if I stop early?

Refund policies vary by provider. Some programs prorate unused months; others do not refund prepaid fees. Before committing to a multi-month plan, review the cancellation and refund terms in the service agreement, especially if you are new to GLP-1 therapy and uncertain how you will tolerate the medication.

Sources

• PlexusDx product pages and internal pricing table, captured July 17–23, 2026 and September 24, 2026
• Mochi Health pricing page and checkout flow, captured September 4, 2026
• Henry Meds pricing page and product pages, captured September 4, 2026
• Eden pricing page and checkout flow, captured September 4, 2026
• Found pricing page, captured July 20 and September 4, 2026
• Embody, Peak Wellness, TrimRx pricing pages, captured July 17–23, 2026
• MEDVi pricing page and checkout flow, captured September 4, 2026
• OrderlyMeds pricing page, captured September 4, 2026
• Fridays Health pricing page, captured July 20 and September 4, 2026
• Ro Body Program pricing page, captured July 20 and September 4, 2026
• Hims & Hers pricing page, captured September 4, 2026
• WeightWatchers Clinic pricing page, captured September 4, 2026
• Trustpilot profiles for PlexusDx (trustpilot.com/review/plexusdx.com, captured September 9, 2026), Mochi Health, Henry Meds, Eden, MEDVi, OrderlyMeds, Fridays Health, Ro, Hims & Hers, WeightWatchers (all captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.